|173.69||+0.3300||+0.19%||Vol 4.28M||1Y Perf 16.84%|
|Aug 5th, 2021 16:00 DELAYED|
|- -||0.11 0.06%|
|Target Price||187.22||Analyst Rating||Moderate Buy 1.56|
|Potential %||7.79||Finscreener Ranking||★★+ 47.34|
|Insiders Trans % 3/6/12 mo.||-/-/-100||Value Ranking||★★+ 48.28|
|Insiders Value % 3/6/12 mo.||-/-/-100||Growth Ranking||★★★+ 56.48|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-100||Income Ranking||★★+ 44.11|
|Price Range Ratio 52W %||97.80||Earnings Rating||Neutral|
|Market Cap||457.39B||Earnings Date||21st Jul 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||2.28|
|EPS Growth Next 5 Years %||6.50|
|Avg. Weekly Volume||4.58M|
|Avg. Monthly Volume||5.89M|
|Avg. Quarterly Volume||6.35M|
Johnson & Johnson (NYSE: JNJ) stock closed at 173.69 per share at the end of the most recent trading day (a 0.19% change compared to the prior day closing price) with a volume of 4.29M shares and market capitalization of 457.39B. Is a component of S&P 500, Dow Jones 30, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 136400 people. Johnson & Johnson CEO is Alex Gorsky.
The one-year performance of Johnson & Johnson stock is 16.84%, while year-to-date (YTD) performance is 10.36%. JNJ stock has a five-year performance of 40.73%. Its 52-week range is between 133.65 and 174.59, which gives JNJ stock a 52-week price range ratio of 97.80%
Johnson & Johnson currently has a PE ratio of 25.90, a price-to-book (PB) ratio of 6.89, a price-to-sale (PS) ratio of 5.08, a price to cashflow ratio of 19.00, a PEG ratio of 2.32, a ROA of 10.61%, a ROC of 18.25% and a ROE of 26.81%. The company’s profit margin is 19.92%, its EBITDA margin is 31.20%, and its revenue ttm is $89.19 Billion , which makes it $33.88 revenue per share.
Of the last four earnings reports from Johnson & Johnson, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.28 for the next earnings report. Johnson & Johnson’s next earnings report date is -.
The consensus rating of Wall Street analysts for Johnson & Johnson is Moderate Buy (1.56), with a target price of $187.22, which is +7.79% compared to the current price. The earnings rating for Johnson & Johnson stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Johnson & Johnson has a dividend yield of 2.46% with a dividend per share of $4.24 and a payout ratio of 72.00%.
Johnson & Johnson has a Buy technical analysis rating based on Technical Indicators (ADX : 9.67, ATR14 : 1.89, CCI20 : 97.36, Chaikin Money Flow : 0.09, MACD : 1.72, Money Flow Index : 69.13, ROC : 3.11, RSI : 65.73, STOCH (14,3) : 90.29, STOCH RSI : 0.24, UO : 56.90, Williams %R : -9.71), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Johnson & Johnson in the last 12-months were: Alex Gorsky (Option Excercise at a value of $0), Ashley McEvoy (Option Excercise at a value of $0), Jennifer L. Taubert (Option Excercise at a value of $0), Joaquin Duato (Option Excercise at a value of $0), Joseph J. Wolk (Option Excercise at a value of $0), Kathryn E. Wengel (Option Excercise at a value of $1 027 323), Kathryn E. Wengel (Sold 16 115 shares of value $2 473 937 ), Michael E. Sneed (Option Excercise at a value of $6 799 952), Michael E. Sneed (Sold 109 324 shares of value $16 718 918 ), Michael H. Ullmann (Option Excercise at a value of $0), Paulus Stoffels (Option Excercise at a value of $0), Peter M. Fasolo (Option Excercise at a value of $0), Robert J. Decker (Option Excercise at a value of $0), Thibaut Mongon (Option Excercise at a value of $0)
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.